Nurix Therapeutics (NRIX) Current Taxes (2019 - 2022)
Nurix Therapeutics (NRIX) posted quarterly Current Taxes of $41000.0 for Q3 2022, up 10.81% year-over-year from $37000.0 in Q3 2021, and up 57.69% quarter-over-quarter from $26000.0 in Q2 2022.
Analysis
Nurix Therapeutics (NRIX) Current Taxes (2019 - 2022) Analysis & Trends
Nurix Therapeutics (NRIX) has reported Current Taxes for 4 consecutive years, with $41000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Current Taxes rose 10.81% year-over-year to $41000.0; the TTM figure through Aug 2022 stood at $41000.0 (up 10.81% YoY), while the FY2021 annual figure was $75000.0, up 1.35% from the prior year.
- Current Taxes climbed to $41000.0 in Q3 2022 per NRIX's latest filing, from $26000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $325000.0 in Q1 2021 and bottomed at $26000.0 in Q2 2022.
- Historically, Current Taxes has averaged $77555.6 across 4 years, with a median of $41000.0 in 2022.
- Annual changes were most pronounced in 2020 — Current Taxes soared 124.24% — and 2022, when it tumbled 83.69%.
- Nurix Therapeutics' Current Taxes stood at $33000.0 in 2019, then surged by 124.24% to $74000.0 in 2020, then increased by 1.35% to $75000.0 in 2021, then tumbled by 45.33% to $41000.0 in 2022.
- Business Quant data shows NRIX's Current Taxes at $41000.0 in Q3 2022, $26000.0 in Q2 2022, and $53000.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 76.32 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Nurix Therapeutics | 2.90 Bn | 2.46 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2022 | 41,000.00 |
| May 31, 2022 | 26,000.00 |
| Feb 28, 2022 | 53,000.00 |
| Nov 30, 2021 | 75,000.00 |
| Aug 31, 2021 | 37,000.00 |
| Feb 28, 2021 | 325,000.00 |
| Nov 30, 2020 | 74,000.00 |
| Aug 31, 2020 | 34,000.00 |
| Nov 30, 2019 | 33,000.00 |